Clinical Trials Logo

Clinical Trial Summary

The concerned patients are children and adults suffering from idiopathic interstitial pneumonias, other chronic fibrosing interstitial pneumonias with a progressive phenotype, and interstitial pneumonia associated with Scleroderma and related cases of patients carrying a mutation on one of the telomere-associated genes. This is a national, observational, longitudinal, multicenter study that will be conducted retrospectively and prospectively. It aims to collect consistent and comparable clinical data for patients and their relatives, whether they carry a mutation or not, affected by diffuse idiopathic interstitial pneumopathy. The expected duration of the study, including data analysis, is approximately 10 years (5 years for participant enrollment and 5 years of follow-up, in addition to the steps for data management and statistical analyses). Each participating center will inform every participant by providing an information sheet, and their written consent will be obtained before including them in the study and commencing data collection. Prospective medical data will be collected at 6 months to 1 year after enrollment and then at least once per year for patients up to 5 years and 5 years for their relatives. Participants will complete a self-questionnaire during their regular follow-up consultations or by accessing a secure interface.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06036719
Study type Observational
Source Institut National de la Santé Et de la Recherche Médicale, France
Contact Vincent Cottin, Pr
Phone (33) 4 27 85 77 00
Email vincent.cottin@chu-lyon.fr
Status Recruiting
Phase
Start date January 19, 2022
Completion date March 19, 2031

See also
  Status Clinical Trial Phase
Recruiting NCT05828953 - Anlotinib Capsules in the Treatment for IPF/PF-ILDs Phase 2/Phase 3
Active, not recruiting NCT02951416 - Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
Recruiting NCT00470327 - A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Completed NCT00512967 - The Occurence of Inflammation and Oxidative Stress in Lung Diseases N/A
Completed NCT02689102 - Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD. N/A
Completed NCT02796781 - Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases Phase 1/Phase 2
Completed NCT00129701 - Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation N/A
Recruiting NCT04855305 - Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease Phase 2
Recruiting NCT01858259 - Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis N/A
Recruiting NCT06068647 - Ultrasound and Respiratory Physiological Signals in Lung Diseases N/A
Enrolling by invitation NCT05455437 - Monitoring and Evaluation Study of Project ECHO for ILD
Recruiting NCT01211015 - Endoplasmic Reticulum Stress in Chronic Respiratory Diseases N/A
Recruiting NCT04370158 - Interstitial Lung Diseases Cohort Study in China
Enrolling by invitation NCT05727852 - Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Completed NCT02711657 - Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease. N/A
Active, not recruiting NCT00267800 - Database of Interstitial Lung Diseases N/A
Completed NCT02763540 - Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD N/A
Completed NCT02549248 - Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology N/A
Enrolling by invitation NCT02509364 - Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) N/A
Completed NCT00741572 - Individual Sensitivity for Interstitial Lung Diseases N/A